CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the leading media network dedicated to the global legal cannabis, CBD and psychedelics industries, today announced an article covering FinCanna Capital Corp. (CSE: CALI) (OTCQ: FNNZF).
FinCanna Capital Corp.
To view an enhanced version of this graphic, please visit:
When cannabis legalization started to gain momentum in 2012 with Washington and Colorado legalizing recreational marijuana, everyone knew it was going to be a big industry. For nearly a decade now, the investment community has ridden the volatility of the emerging market that generated $13.8 billion in sales in North America in 2019. Analysts don’t expect a slowdown, calling for the U.S. market alone to reach $43.9 billion by 2024, underpinning bullishness in so-called “pot stocks,” including leading growers Canopy Growth Corp. and Tilray recently printing new 52-week highs.
Investors have different options to get market exposure, some that are congested like licensed producers, and others that carry a high risk/reward profile like cannabis-focused biotechs. There are also drink makers, agriculture products, ancillary services and more, many of which are lumped together in exchange traded funds with built-in diversification.
Of course, no matter what the business segment, it takes money to operate and that’s where capital company FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) has set its sights on capturing market. Led by seasoned vets of the financial industry, the company is employing a royalty model, a business strategy that sets it apart from nearly everyone else in the cannabis space.
Royalty (sometimes called “streaming”) models have long been used successfully in other industries, and FinCanna is the only publicly listed company that is focused on royalty financing in the cannabis space with some key improvements. In mining, for instance, a royalty financing company will provide cash to help develop a gold mine in exchange for a future royalty payment calculated as a percentage of the gold produced or sold, which is typically for the life of mine. FinCanna’s royalties, however, are in perpetuity with no end date, and FinCanna’s royalties are corporate wide, so royalties are earned on 100% of all revenues of its investee companies.
In addition to the opportunity for a lucrative return, another benefit of a royalty model is found in the corporate structure, as royalty companies typically run lean and deliver a high revenue per employee. Consider metal streaming company Wheaton Precious Metals, a $17.3 billion company that generated $307 million and net earnings of $149.9 million from its portfolio of royalty deals during the third quarter of 2020. Wheaton has 39 employees.
FinCanna offers a royalty opportunity to those operating in the legal cannabis markets, earning its revenue from royalties paid by its investee companies that are calculated based on a percentage of their total revenues. The model is beneficial across the board, offering companies attractive, non-dilutive alternatives to debt or equity financing and giving investors in FinCanna exposure to a diverse and vetted group of companies. Without high-cost operations, the company can scale very quickly as it identifies best-in-breed companies seeking fresh growth capital.
FinCanna is taking a measured approach, initially targeting the massive California market. With nearly 40 million people, California is the largest economy in the U.S. and fifth largest economy in the world. Both recreational and medical marijuana are legal in the state, which translates to California being a juggernaut cannabis economy too, accounting for 21% of the $14.9 billion in legal cannabis sales globally in 2019.
The company is led by CEO Andriyko Herchak, CPA, CA, who brings more than two decades of executive leadership experience with public companies to FinCanna. Herchak knows success, serving as CFO of Hathor Exploration, which was the subject of a bidding war between Cameco and Rio Tinto, ultimately being sold to Rio for $654 million in 2011. Herchak was also previously CFO at an international sales and marketing company generating $1.4 billion in annual sales in addition to a number of other C-suite and director positions during his career.
Robert Scott, CPA, CA, CFA, serves as CFO at FinCanna and from there the rest of the team is directors and advisors, embodying the spirit of a royalty model running lean in overhead. The group of directors and advisors reads like a Who’s Who in finance, business, law and legal cannabis. They include people like Morris Reid, a globally recognized corporate and political strategist and partner at high-stakes public strategy firm Mercury, as Chairman; Holger Heims, Managing Partner of Switzerland’s Falcon Equity Advisors GmbH, as Director; and a solid team of advisors.
FinCanna has three portfolio companies that demonstrate its mission for diversity. QVI, Inc., operating as “The Galley,” is a cannabis-infused product manufacturer in Sonoma. With an emphasis on quality and compliance, The Galley is a fully-license 8,300 sq. ft. facility built to FDA and California Department of Public Health standards, producing and co-packing a wide array of products, including edibles, topicals, tinctures, chocolates, gummies, beverages, vapes, pre-rolls, flowers and more.
Per the royalty agreement, FinCanna receives 20% of QVI’s revenues, paid in cash every month. With the edibles market booming, QVI is in an enviable position, already onboarding 25+ brands since The Galley launched operations in July 2020. QVI is FinCanna’s largest investment, being owed an Annual Supplemental Payment in addition to the royalty that equates to FinCanna entitled to at least 70% of QVI’s after-tax profits annually, payable in cash. If QVI is acquired or goes public, FinCanna gets 70% of the sale’s proceeds.
The Galley’s clients currently are mostly small to medium sized brands, with management also beginning to win contracts with larger brands both in the state and those looking to enter the California market. Any new manufacturing deals are like a gold miner striking a new vein for Wheaton; it goes right into the revenue stream for FinCanna.
Cultivation Technologies Inc. (CTI) operates as an award-winning extraction and manufacturing enterprise in Palm Desert branded “Coachella Manufacturing.” From its state-licensed 5,200 sq. ft. facility, CTI produces high-end Butane Hash Oil (BHO) concentrates for premium brands and cultivators throughout California. Its first investment, CTI started operating in 2017 and generating royalties for FinCanna in the second half of 2020. CTI has recently committed to expanding its core business, which FinCanna believes will result in “…a large increase in high margin royalty revenues...”
In this case, FinCanna earns a perpetual royalty of 10% of CTI’s consolidated revenue, with 5% paid in cash monthly and the other 5% deferred until pre-set milestones are met. The contract further stipulates that if CTI is sold, FinCanna is entitled to 25-50% (dependent upon certain conditions) of the sale’s proceeds.
On February 4th, the company announced that it sold a portion of its underutilized extraction equipment to CTI in exchange for an increased royalty stream. The new equipment will increase the investee’s current capacity by as much as 500%.
With investments in manufacturing, FinCanna is now also participating in the technology space, acquiring eZGreen Compliance in August. eZGreen operates a state-of-art, HIPAA (Health Insurance Portability and Accountability Act) compliant point-of-sale software for dispensaries. Subsequent to completing the transaction in August, the company partnered with a “highly regarded” marketing company with a deep reach into the California dispensary market. No royalty stream here, all profits from eZGreen sales and services go directly to FinCanna’s coffers.
2020 was a tumultuous year, to say the least, and particularly hard on California. In addition to the COVID-19 pandemic affecting businesses, the state dealt with out-of-control wildfires that put additional pressure on all levels of the economy. Things are looking brighter for 2021 on the coronavirus front and the cannabis community is buzzing about the Biden administration, which is expected to be proactive towards cannabis legislation, including hopes that it will be de-scheduled or at least re-scheduled in the Controlled Substance Act to allow even greater consumer access and commerce and much improved income tax economics, which should give additional lift to cannabis stocks.
For FinCanna’s cautionary note regarding forward-looking information visit:
About CFN Enterprises Inc.
CFN Enterprises Inc. (OTCQB: CNFN) is a digital media and ecommerce company focused on advancing businesses and brands in highly regulated emerging industries across the globe. CFN connects investors with new market opportunities while helping consumers find innovative products that enhance their lives. Learn more at www.cfnenterprisesinc.com.
CFN Enterprises Inc. Media Contact:
CFN Enterprises Inc.
+001 (833) 420-CNFN
Use of Forward-looking Statements
This press release may contain forward-looking statements from CFN Enterprises Inc. within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995 and federal securities laws. For example, when CFN Enterprises Inc. describes Client business, and uses other statements containing the words “believes,” “anticipates,” “plans,” “expects,” “will” and similar expressions, CFN Enterprises Inc. is using forward-looking statements. These forward-looking statements are based on the current expectations of the management of CFN Enterprises Inc. only, and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. The following factors, among others, could cause actual results to differ materially from those described in the forward-looking statements: regulatory and licensing risks; changes in general economic, business and political conditions, including changes in the financial markets; the regulatory landscape and enforcement related to cannabis, including political risks and risks relating to regulatory change; changes in applicable laws; compliance with extensive government regulation; public opinion and perception of the cannabis industry; we may be unable to retain or attract key employees whose knowledge is essential to the development of our products and services; or, loss of market share and pressure on pricing resulting from competition, which could cause the actual results or performance of CFN Enterprises Inc. to differ materially from those contemplated in such forward-looking statements. Except as otherwise required by law, CFN Enterprises Inc. undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. For a more detailed description of the risk and uncertainties affecting CFN Enterprises Inc., reference is made to CFN Enterprises Inc.’s reports filed from time to time with the Securities and Exchange Commission.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/73995
News Provided by Newsfile via QuoteMedia
FinCanna Capital Corp.
Philip Young, CEO and Director of Lobe, stated, “We are honored to welcome Bart to our Advisory Board. His first-hand experience on and off the field are tremendously valuable as we continue our research involving mild traumatic brain injuries and PTSD. These issues are prevalent in contact sports and we believe that athletes will play a prominent role in the continued acceptance of psychedelic medicines as legitimate treatment. We look forward to working with Bart as we seek to forge long-term strategic relationships.”
HempFusion Wellness Submits Novel Foods Dossier to the United Kingdom’s Regulatory Food Safety Agency
HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that it has submitted its dossier to the United Kingdom’s Regulatory Food Safety Agency (the “FSA”).
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210303005322/en/
MustGrow Isolates and Concentrates a Mustard-Derived Molecule that Acts as a Systemic, Non-Selective Bioherbicide
- MustGrow has isolated and concentrated a new mustard-derived extract, thiocyanate.
- Thiocyanate is soil active and translocated in the plant as a systemic, non-selective bioherbicide (natural weed-killer).
- Greenhouse weed treatment studies have commenced with this new bioherbicide extract.
MustGrow Biologics Corp. (CSE: MGRO) (OTCQX: MGROF) (FSE: 0C0) (the “Company”, “MustGrow”) is pleased to announce that it has isolated and concentrated an additional molecule, thiocyanate, from mustard seed. Thiocyanate, which is responsible for the systemic activity behind the mustard plant’s natural herbicidal (weed-killer) properties, is the third molecule from mustard seed that MustGrow has isolated, extracted, and concentrated. MustGrow had previously reported herbicidal proof-of-concept success without isolating thiocyanate and now expects to build on those studies with this additional herbicidal mode-of-action now identified.
Thiocyanate extract has the potential to be a natural organic non-selective bioherbicide that is soil active with systemic translocated properties. Systemic activity, or the ability of the active ingredient to move from soil, to roots, and then to stem and leaves, is particularly significant given that the leading synthetic herbicide glyphosate is not soil active, and only acts on the above ground parts of the weed it contacts. MustGrow believes a tremendous opportunity exists to potentially replace or compliment glyphosate in certain systems, by providing a natural organic solution. Globally, glyphosate is being phased out, including recent announcements by Germany and Mexico by 2024. France recently announced glyphosate restrictions but stopped short of a full ban because of a lack of non-chemical alternatives.
Koios Expands Texas Presence with Upcoming Placements in Select Stores of Drug Emporium, a Pharmacy Chain in TX, AR, LA
Drug Emporium is a chain of “big box” pharmacies in Texas, Arkansas, and Louisiana with standard pharmacy departments as well as “store-within-a-store” features such as “Vitamins Plus”. This month, the Company’s KOIOS™ and Fit Soda™ beverage products will be placed in select Texas locations of Drug Emporium, complementing existing placements of the Company’s products in the state of Texas, including in more than 100 HEB supermarkets.
Koios Beverage Corp. (CSE: KBEV; OTC: KBEVF) (the “Company” or “Koios”) is pleased to announce that beginning this month, all five flavours of its KOIOS ™ nootropic beverage and all four flavours of its Fit Soda ™ functional beverage will be carried in select Texas locations of Drug Emporium, a “big box” pharmacy chain with stores in Texas (population 29 million), Arkansas (population 3 million), and Louisiana (population 4.65 million). In late 2020, the Company announced that its Fit Soda ™ functional beverage product is now carried in more than 100 HEB supermarkets in Texas . Additionally, the Company announced last week that its KOIOS ™ nootropic beverage product was to be added to all locations of Louisiana supermarket chain Matherne’s including its storefront located across from the Louisiana State University’s Tiger Stadium which is the eighth-largest stadium in the world. The Company has sustained its focus on placing its beverage products with regional grocery chains who can play a key role in accelerating market penetration in a given geographic region. By adding to its existing presence in the southeastern United States through local chains such as Drug Emporium and national banner retailers such as Walmart, the Company believes that it is favourably positioned to gain greater market share in the functional beverages category. The Company’s beverage products are currently sold in more than 4,000 stores in the United States.
Love Hemp Group PLC (AQSE:LIFE)(OTCQB:WRHLF), is pleased to announce that, further to the Company’s announcement on 15 February 2021, the change of name from World High Life Plc to Love Hemp Group PLC has become effective
All share certificates that are presently in the hands of investors will be valid and do not need to be exchanged for new share certificates.